why choose us

300×250 Ad Slot

Research Article: 4th booster-dose SARS-CoV-2 heterologous and homologous vaccination in rheumatological patients

Date Published: 2024-07-26

Introduction:
Objective: to evaluate the immune response to the SARS-CoV-2 vaccines in adults with immune-mediated rheumatic diseases (IMRDs) in comparison to healthy individuals, observed 1-20 weeks following the fourth vaccine dose. Additionally, to evaluate the impact of immunosuppressive therapies, vaccination schedules, the time interval between vaccination and sample collection on the vaccine’s immune response.

Read more

300×250 Ad Slot